Find uplifting stories about heroes, innovations, and solutions
8299 results for "blood disorder treatment"
Patients with essential thrombocythemia finally have a new treatment option after nearly three decades. Taiwan just approved BESREMi, a therapy that could help thousands manage this rare blood disorder more effectively.
Blood cancer patients in Kansas can now access a one-time therapy that could replace lifelong chemotherapy cycles. The breakthrough CAR T-cell treatment genetically modifies patients' own immune cells to fight cancer.
A groundbreaking immunotherapy combination helped 8 in 10 multiple myeloma patients live two years without their cancer getting worse, compared to just 5 in 10 with standard treatment. The global trial involving over 860 patients offers renewed hope for those facing this difficult blood cancer.
A simple blood test is helping doctors track how well cancer treatments work without waiting months for scans. The breakthrough could spare patients from ineffective therapies and catch recurrences earlier than ever before.
Australia has become the first country outside the US to approve a revolutionary therapy for chronic graft-versus-host disease, a serious complication affecting nearly half of blood cancer patients who receive donor stem cell transplants. The treatment was developed from world-first research led by Australian scientists over a decade ago.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Hundreds of patients with rare blood cancers in England can now access two breakthrough treatments that work from home or offer better survival odds. The new approvals bring hope to families facing diseases that once had few options.
Scientists developed a simple blood test that reveals which breast cancer treatments will work before patients waste precious time on ineffective options. The breakthrough could help 2 million people diagnosed globally each year get the right treatment faster.
Children as young as 5 can now benefit from groundbreaking CRISPR gene therapy for severe blood disorders. New research shows the treatment works safely in younger kids, potentially preventing years of disease complications.
Stanford and Mayo Clinic researchers developed a simple blood test that reveals how cells around tumors behave, helping doctors choose the most effective cancer treatments. The breakthrough could transform cancer care from guesswork into precision medicine.
Scientists discovered that ruxolitinib, a medication for blood disorders, helps the body fight malaria more effectively and build stronger immunity. The breakthrough could save lives among the 600,000 people, mostly young children, who die from malaria each year.
After surprising companies with a rejection in January, the FDA has agreed that existing trial data for a rare blood cancer therapy is sufficient for approval review. The agency's reversal gives new hope to patients with limited treatment options.
Scientists discovered why some bladder cancer patients don't respond to immunotherapy by linking common blood markers to immune suppression inside tumors. The breakthrough could help doctors identify resistant cases earlier and develop better combination treatments.
Researchers developed a blood test that could help doctors decide which chemotherapy will work best for young men with testicular cancer. This breakthrough could spare patients from aggressive treatments that won't help them while identifying better options.
A common, inexpensive blood pressure medication could make certain cancer treatments work better, according to promising new research. Scientists discovered that telmisartan helps the immune system recognize and attack tumors when combined with existing cancer drugs.
Princeton now offers specialized eating disorder care through a new collaboration that brings together expert teams. The program provides intensive support for people who need more than weekly appointments but don't require hospital stays.
Five people with a life-threatening blood disorder no longer need regular transfusions after receiving a groundbreaking gene therapy in China. The treatment could bring hope to 350 million carriers of thalassaemia worldwide.
Scientists discovered that human red blood cell production works differently than decades of mouse-based research suggested. The breakthrough could lead to better treatments for anemia and blood disorders.
Johnson & Johnson's experimental treatment Imaavy has now passed two major clinical trials for a rare autoimmune blood disorder, bringing hope to patients whose own immune systems attack their red blood cells. The FDA is already fast-tracking its review under priority status.
Mount Sinai researchers made old blood stem cells behave like young ones again by repairing tiny cellular recycling centers, boosting their regenerative power eightfold. This discovery could lead to treatments that help elderly people maintain healthier immune systems and reduce risks of blood disorders.
Showing 20 of 8299